Research Note

 
Stock Quotes for Research Note top ^
  • Industry: Consumer Electronics
  • Sector: Technology
  • Stock Style: Small Value
Sign-up for note investment picks

 
News Articles for Research Note top ^
2015/1/22
Merck (NYSE:MRK), known as MSD outside the United States and Canada, on behalf of its wholly owned subsidiary Cubist Pharmaceuticals, Inc., today announced that, in connection with the completion of the acquisition of Cubist by Merck, Cubist has commenced a tender offer (the “ Convertible Notes Tender Offer ”) to repurchase, at the option of each holder, any and all of its outstanding 2.50% Convertible Senior Notes due 2017 (the “ 2017 Convertible Notes ”), 1.125% Convertible Senior Notes due 2018 (the “ 2018 Convertible Notes ”) and 1.875% Convertible Senior Notes due 2020 (the “ 2020 Convertible Notes ” and together with the 2017 Convertible Notes and 2018 Convertible Notes, the “ Convertible Notes ”). Earlier in the day on January 21, 2015, Merck completed the tender offer for all of the outstanding shares of common stock of Cubist, consummated the merger of
Sign-up for Merck, on Behalf of its Wholly Owned Subsidiary, Cubist Pharmaceuticals, Announces Tender Offer for Cubist’s 2.50% Convertible Senior Notes Due 2017, 1.125% Convertible Senior Notes due 2018 and 1.875% Convertible Senior Notes due 2020 investment picks
2015/2/23
DEERFIELD, Ill.
Sign-up for Mondelez International Announces $2,000,000,000 Cash Tender Offer for Certain Notes investment picks
2014/12/3
PROS Holdings, Inc. (NYSE: PRO) (the “Company”) today announced that it intends to offer, subject to market conditions and other factors, $125 million aggregate principal amount of convertible senior notes due 2019 (the “Convertible Notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The Company expects to grant an option to the initial purchasers to purchase up to an additional $18.75 million aggregate principal amount of Convertible Notes.
Sign-up for PROS Holdings, Inc. Announces Private Offering of $125 Million of Convertible Senior Notes due 2019 investment picks
2014/12/5
BAUDETTE, Minn.
Sign-up for ANI Pharmaceuticals Announces Pricing of Upsized $125 Million Convertible Notes Offering investment picks
2014/12/5
PROS Holdings, Inc. (NYSE:PRO) (the “Company”) today announced the pricing of its $125 million aggregate principal amount of convertible senior notes due 2019 (the “Convertible Notes”). The Convertible Notes are being offered in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The Company granted an option to the initial purchasers to purchase up to an additional $18.75 million aggregate principal amount of Convertible Notes.
Sign-up for PROS Holdings, Inc. Announces Pricing of Private Offering of $125 Million of Convertible Senior Notes due 2019 investment picks
2015/1/7
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1168015&ProfileId=051205&sourceType=1 SAN JOSE, CA --
Sign-up for Brocade Announces Plans to Offer $500 Million in Convertible Senior Notes investment picks
2014/12/22
Martin Marietta Materials, Inc. (“Martin Marietta”) (NYSE:MLM) today announced the expiration of its offers (collectively the “exchange offers”) to exchange all of its outstanding Floating Rate Senior Notes due 2017 (the “Original 2017 Notes”) for its Floating Rate Senior Notes due 2017, which are registered under the Securities Act of 1933, as amended (the “Securities Act”) (the “Exchange 2017 Notes”), and all of its outstanding 4.250% Senior Notes due 2024 (the “Original 2024 Notes”) and, together with the Original 2017 Notes, the “Original Notes” for its 4.250% Senior Notes due 2024, which are registered under the Securities Act (the “Exchange 2024 Notes” and, together with the Exchange 2017 Notes, the “Exchange Notes”). The exchange offers expired at 5:00 p.m., New York City time, on December 19, 2014.
Sign-up for Martin Marietta Materials, Inc. Announces Expiration of Registered Exchange Offers for its Floating Rate Senior Notes due 2017 and 4.250% Senior Notes due 2024 investment picks
2014/12/16
B/E Aerospace, Inc. (the “Company”) (NASDAQ:BEAV) today announced that, in connection with its cash tender offers (the “Tender Offers”) for any and all of its 6.875% Senior Notes due 2020 (the “2020 Notes”) and 5.25% Senior Notes due 2022 (the “2022 Notes” and together with the 2020 Notes, the “Notes”) and related consent solicitations (the “Consent Solicitations” and, together with the Tender Offers, the “Offers”), it has received the requisite consents for certain proposed amendments to the indentures governing the Notes (the “Indentures”). The terms and conditions of the Offers are described in the Offer to Purchase and Consent Solicitation Statement, dated November 28, 2014 (the “Statement”) and the related Consent and Letter of Transmittal, which has been sent to holders of Notes.
Sign-up for B/E Aerospace Announces Receipt of Requisite Consents for Its Previously Announced Tender Offers for Any and All of Its Outstanding 6.875% Senior Notes Due 2020 and 5.25% Senior Notes Due 2022 and Related Consent Solicitations investment picks
2015/1/9
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1168302&ProfileId=051205&sourceType=1 SAN JOSE, CA --
Sign-up for Brocade Announces Pricing of $500 Million Convertible Senior Notes Offering investment picks
2015/1/29
WILMINGTON, Del., Jan.
Sign-up for Navient announces Cash Tender Offer for its 6.25% Medium Term Notes, Series A due Jan. 25, 2016 investment picks
2015/2/23
Merck (NYSE:MRK), known as MSD outside the United States and Canada, on behalf of its wholly owned subsidiary Cubist Pharmaceuticals, Inc., today announced the results of its tender offer (the “ Convertible Notes Tender Offer ”) pursuant to which each holder of Cubist’s 2.50% Convertible Senior Notes due 2017 (the “ 2017 Convertible Notes ”), 1.125% Convertible Senior Notes due 2018 (the “ 2018 Convertible Notes ”) and 1.875% Convertible Senior Notes due 2020 (the “ 2020 Convertible Notes ” and together with the 2017 Convertible Notes and 2018 Convertible Notes, the “ Convertible Notes ”) had the right (the “ Fundamental Change Repurchase Right ”), at such holder’s option, to require Cubist to repurchase for cash all of such holder’s Convertible Notes, or any portion of the principal amount thereof that is equal to $1,000 or an integral multiple of $1,000
Sign-up for Merck, on Behalf of Its Wholly Owned Subsidiary Cubist Pharmaceuticals, Announces Results of Tender Offer for Cubist’s 2.50% Convertible Senior Notes Due 2017, 1.125% Convertible Senior Notes Due 2018 and 1.875% Convertible Senior Notes Due 2020 investment picks
2015/2/11
NEW YORK , Feb.
Sign-up for Verizon Announces Exchange Offers for Certain Outstanding Notes From Eligible Holders investment picks
2015/2/9
Citigroup Inc. (“ Citigroup ”) today announced the commencement of offers to purchase for cash certain of its notes of the series set forth in the table below up to an aggregate principal amount with respect to each series of notes (each, a “ Maximum Series Tender Cap ”). The offer to purchase each series of Notes is referred to as an “ Offer ” and all such offers are referred to collectively as the “ Offers .” The Notes had an aggregate principal amount outstanding of approximately U.S. $3.52 billion as of February 6, 2015.
Sign-up for Citigroup Inc. Announces Offers to Purchase Three Series of Outstanding Notes investment picks
2015/2/27
Rovi Corporation (NASDAQ:ROVI) announced today the pricing of $300 million principal amount of 0.500% Convertible Senior Notes due 2020 (the “Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). In addition, Rovi has also granted the initial purchasers for the offering an option to purchase up to an additional $45 million principal amount of Notes from Rovi solely to cover over-allotments.
Sign-up for Rovi Corporation Announces Pricing of $300 Million in Convertible Senior Notes investment picks
2015/2/25
Rovi Corporation (NASDAQ:ROVI) announced today that it intends to offer, subject to market and other conditions, $300 million principal amount of Convertible Senior Notes due 2020 (the "Notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). In addition, Rovi expects to grant the initial purchasers for the offering an option to purchase up to an additional $45 million principal amount of Notes from Rovi solely to cover over-allotments.
Sign-up for Rovi Corporation Announces Plans to Offer $300 Million in Convertible Senior Notes investment picks
2014/12/4
-Consent Payment Deadline Pursuant to its Tender Offer for its Outstanding 8.375% Notes due 2020 Has Expired -Remaining 2020 Notes Called for Redemption DULUTH, Ga.
Sign-up for Asbury Automotive Group, Inc. Announces Closing of Offering of $400.0 million of 6.0% Senior Subordinated Notes due 2024 and Amendment of Senior Secured Credit Facility investment picks
2014/12/4
BAUDETTE, Minn.
Sign-up for ANI Pharmaceuticals, Inc. Announces $100 Million Public Offering of Convertible Notes investment picks
2014/12/10
Citigroup Inc. (“ Citigroup ”) announced today that it has increased the maximum aggregate principal amounts of specified series of notes (the “ Notes ”) that it will accept (each, a “ Maximum Series Tender Cap ”) and the aggregate principal amounts of Notes that were validly tendered and not validly withdrawn prior to 5:00 p.m., New York City time, on December 9, 2014 (the “ Early Tender Date ”) pursuant to its previously announced cash tender offers (each, an “ Offer ” and, collectively, the “ Offers ”), as set forth in the table below.
Sign-up for Citigroup Announces Upsizing and Early Tender Results of Offers to Purchase Specified Series of Outstanding Notes investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Research Note
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Research North  |  Next: Research Objectives